Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACLX | KYMR | MIRM | ||
| Company | Arcellx Inc | Kymera Therapeutics Inc | Mirum Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 115.04 | 84.08 | 106.73 | ||
| High | 115.13 | 86.54 | 110.49 | ||
| Low | 114.99 | 83.85 | 106.22 | ||
| Latest | 115.07 | 86.26 | 110.08 | ||
| Change | +0.04 | +3.55 | +4.27 | ||
| % Change | +0.03% | +4.29% | +4.04% | ||
| Volume | 14,666,200 | 426,800 | 1,005,700 | ||
| 20-Day Average Volume | 1,561,025 | 507,315 | 710,335 | ||
| Previous Close | 115.03 | 82.71 | 105.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 114.90 | 85.79 | 97.04 | ||
| 20-Day Raw Stochastic | 88.68% | 68.94% | 98.15% | ||
| 20-Day Relative Strength | 77.96 | 53.46 | 67.96 | ||
| Weighted Alpha | +17.51 | +84.93 | +142.46 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 04/20/26 | +5.83% since 04/29/26 | +16.86% since 04/29/26 | ||
| Low | 114.98 on 04/22/26 | 77.64 on 04/30/26 | 88.34 on 05/04/26 | ||
| High | 115.13 on 04/27/26 | 86.54 on 05/06/26 | 110.49 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +0.44% since 03/27/26 | +1.16% since 04/06/26 | +14.38% since 04/06/26 | ||
| Low | 114.60 on 03/30/26 | 77.64 on 04/30/26 | 88.34 on 05/04/26 | ||
| High | 115.13 on 04/27/26 | 90.14 on 04/15/26 | 110.49 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | +67.96% since 01/27/26 | +8.38% since 02/06/26 | +9.57% since 02/06/26 | ||
| Low | 63.15 on 02/20/26 | 73.31 on 03/24/26 | 84.33 on 03/09/26 | ||
| High | 115.13 on 04/27/26 | 95.90 on 02/26/26 | 110.49 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | +32.72% since 10/27/25 | +41.41% since 11/06/25 | +62.55% since 11/06/25 | ||
| Low | 60.35 on 01/05/26 | 56.75 on 11/07/25 | 63.23 on 12/15/25 | ||
| High | 115.13 on 04/27/26 | 103.00 on 12/08/25 | 110.49 on 05/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,729,293 | 6,803,560 | 6,452,082 | ||
| Shares Outstanding, K | 58,480 | 82,258 | 60,978 | ||
| Annual Sales | 22,290,000 | 39,210,000 | 521,310,000 | ||
| Annual Net Income | -228,930,000 | -311,350,000 | -23,360,000 | ||
| Last Quarter Sales | 1,650,000 | 34,370,000 | 148,930,000 | ||
| Last Quarter Net Income | -58,110,000 | -69,230,000 | -5,730,000 | ||
| 60-Month Beta | 0.25 | 2.06 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.01 on 02/26/26 | -0.71 on 04/30/26 | -0.11 on 02/25/26 | ||
| Earnings Date | 05/14/26 | 08/10/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||